ES547294A0 - Procedimiento de exaltacion de la fluorescencia de un ion detierra rara - Google Patents

Procedimiento de exaltacion de la fluorescencia de un ion detierra rara

Info

Publication number
ES547294A0
ES547294A0 ES547294A ES547294A ES547294A0 ES 547294 A0 ES547294 A0 ES 547294A0 ES 547294 A ES547294 A ES 547294A ES 547294 A ES547294 A ES 547294A ES 547294 A0 ES547294 A0 ES 547294A0
Authority
ES
Spain
Prior art keywords
rare earth
exaltation
fluorescence
procedure
earth ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547294A
Other languages
English (en)
Other versions
ES8706792A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of ES8706792A1 publication Critical patent/ES8706792A1/es
Publication of ES547294A0 publication Critical patent/ES547294A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/77Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/40Rare earth chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES547294A 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara Expired ES8706792A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8414799A FR2570703B1 (fr) 1984-09-26 1984-09-26 Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents

Publications (2)

Publication Number Publication Date
ES8706792A1 ES8706792A1 (es) 1987-07-01
ES547294A0 true ES547294A0 (es) 1987-07-01

Family

ID=9308106

Family Applications (3)

Application Number Title Priority Date Filing Date
ES547294A Expired ES8706792A1 (es) 1984-09-26 1985-09-25 Procedimiento de exaltacion de la fluorescencia de un ion detierra rara
ES557485A Expired ES8801695A1 (es) 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557485A Expired ES8801695A1 (es) 1984-09-26 1987-04-01 Procedimiento de obtencion de complejos macropoliciclicos de tierras ratas
ES557486A Expired ES8801938A1 (es) 1984-09-26 1987-04-01 Procedimiento para la obtencion de comopuestos macropoliciclicos

Country Status (9)

Country Link
US (1) US4927923A (es)
EP (1) EP0180492B1 (es)
JP (3) JPH0655741B2 (es)
KR (1) KR930008210B1 (es)
AT (1) ATE90084T1 (es)
CA (1) CA1329593C (es)
DE (1) DE3587380T2 (es)
ES (3) ES8706792A1 (es)
FR (1) FR2570703B1 (es)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220012A (en) * 1984-09-26 1993-06-15 Compagnie Oris Industrie Sa Macropolycyclic rare earth complexes and application as fluorescent tracers
SE454781B (sv) * 1986-10-17 1988-05-30 Wallac Oy Hybridiseringsforfarande for detektion av polynukleotidsekvens
US5162508A (en) * 1987-12-18 1992-11-10 Compagnie Oris Industrie Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
FR2624862B1 (fr) * 1987-12-18 1990-06-08 Oris Ind Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
US5134232A (en) * 1988-11-14 1992-07-28 The Regents Of The University Of California Fluorescent indicator dyes for alkali metal cations
US5094759A (en) * 1989-03-17 1992-03-10 The University Of Southern Mississippi Method of water treatment using 2,6-substituted aminopyridines and polymer derived therefrom
US5216134A (en) * 1989-10-23 1993-06-01 Wallac Oy Spectrofluorometric method and compounds that are of value for the method
FR2664699B1 (fr) * 1990-07-13 1995-08-18 Cis Bio Int Procede d'amplification du signal d'emission d'un compose luminescent.
EP0554358A4 (en) * 1990-09-27 1995-09-06 Brunswick Corp Chelating agents
EP0493745A1 (en) * 1990-12-21 1992-07-08 Dojindo Laboratories Fluorescent compound, complex, reagent, and specific binding assay employing said reagent
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
FR2680787B1 (fr) * 1991-08-30 1994-11-04 Cis Bio Int Complexes macrocycliques de terres rares et leur utilisation pour reduire les interferences dans un dosage par fluorescence.
ES2133312T3 (es) * 1991-12-05 1999-09-16 Wallac Oy Quelatos de lantanidos luminiscentes.
US5417959A (en) * 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
AU1694895A (en) * 1994-01-28 1995-08-15 Mallinckrodt Medical, Inc. Functionalized aza-bimacrocyclic ligands for imaging applications
US6017496A (en) 1995-06-07 2000-01-25 Irori Matrices with memories and uses thereof
US6329139B1 (en) 1995-04-25 2001-12-11 Discovery Partners International Automated sorting system for matrices with memory
US5792330A (en) * 1995-05-31 1998-08-11 Board Of Regents, The University Of Texas System Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis
FR2768817B1 (fr) * 1997-09-19 1999-12-10 Cis Bio Int Methode homogene pour la detection et/ou la determination de l'activite phosphorylante d'un materiel biologique
FR2769315B1 (fr) * 1997-10-03 2001-06-08 Cis Bio Int Conjugues fluorescents de nucleosides ou de nucleotides, leur procede de preparation et leur utilisation
EP1925320A3 (en) 1998-03-27 2008-09-03 Prolume, Ltd. Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
AU765703B2 (en) 1998-03-27 2003-09-25 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
FR2809817B1 (fr) 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
CA2504481A1 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
EP1597577A4 (en) * 2003-02-10 2007-02-21 Pointilliste Inc SELF-ARRANGING ARRAYS AND ITS APPLICATION
US7018851B2 (en) * 2003-02-13 2006-03-28 Innotrac Diagnostics Oy Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
EP1671128B1 (en) * 2003-09-12 2010-02-17 Life Technologies Corporation Applications of the resonance energy transfer between terbium and GFP
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
WO2005046735A1 (en) * 2003-11-07 2005-05-26 Newport Instruments A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
US20060024722A1 (en) 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof
FR2878850B1 (fr) * 2004-12-02 2008-10-31 Cis Bio Internat Sa Derives de l'inositol-1-phosphate
DE102005020384A1 (de) * 2005-05-02 2006-11-09 Therainvention Gmbh Spektroskopisches Verfahren zum Nachweis von Analyten
JP4559922B2 (ja) * 2005-06-21 2010-10-13 株式会社東芝 蛍光性錯体及びそれを用いた照明装置
FR2890174B1 (fr) 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
FR2890446B1 (fr) 2005-09-05 2008-04-18 Cis Bio Internat Sa Methode de detection d'interaction intracellulaire entre bio-molecules
US20070264678A1 (en) 2005-10-28 2007-11-15 Invitrogen Corporation Kinase and ubiquination assays
US7482444B2 (en) * 2006-03-13 2009-01-27 Wallac Oy Terminating substrates for DNA polymerases
DE102006021406B4 (de) 2006-05-08 2008-08-07 B.R.A.H.M.S Aktiengesellschaft In vitro Verfahren zur Früherkennung von arznei- und suchtmittelinduzierten Leberschäden und zur Erkennung der bereits erreichten Stufe der Leberschädigung
US8216856B2 (en) 2006-08-18 2012-07-10 Abacus Diagnostica Oy Luminescent lanthanide labelling reagents and their use
KR20090094303A (ko) * 2006-11-27 2009-09-04 스미또모 가가꾸 가부시키가이샤 다핵 착체
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
EP2316035A2 (en) * 2008-07-16 2011-05-04 Radiometer Medical ApS Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
FR2936245B1 (fr) 2008-09-23 2012-07-06 Cis Bio Int Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
FR2940286B1 (fr) * 2008-12-19 2011-04-08 Cis Bio Int Nouveaux cryptates de terres rares comportant un motif tetraazatriphenylene
FI20090100A0 (fi) 2009-03-16 2009-03-16 Wallac Oy Biotinidaasimääritys
CA2759885A1 (fr) 2009-04-30 2010-11-04 Etienne Doumazane Procede de detection de composes modulateurs de dimeres de proteines membranaires a domaine vft
FR2949156B1 (fr) 2009-08-13 2016-04-15 Cis-Bio Int Methode de determination de la liaison d'un compose donne a un recepteur membranaire
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
FR2978149B1 (fr) 2011-07-18 2014-01-10 Cisbio Bioassays Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
WO2013042120A2 (en) 2011-09-19 2013-03-28 Proteologics Ltd Synthetic ubiquitins and use thereof in drug screening assays
WO2013124544A1 (fr) 2012-02-22 2013-08-29 Cisbio Bioassays Procede de normalisation de la luminescence emise par un milieu de mesure.
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
WO2014136115A1 (en) 2013-03-07 2014-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-selfabsorbing luminescent solar concentrator
FR3004189B1 (fr) 2013-04-04 2015-09-04 Ecole Norm Superieure Lyon Complexes de lanthanide comprenant au moins deux groupes betaines, utiles comme marqueurs luminescents
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
WO2017089474A1 (en) 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
FR3045053B1 (fr) 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
US9834808B2 (en) 2016-01-21 2017-12-05 SeLux Diagnostics, Inc. Methods for rapid antibiotic susceptibility testing
MX2018008906A (es) 2016-01-21 2019-01-10 Selux Diagnostics Inc Metodos para pruebas rapidas de susceptibilidad antimicrobiana.
CA3033102A1 (en) 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating organ dysfunction
JP7104689B2 (ja) 2016-08-09 2022-07-21 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 有害事象を示すマーカーとしてのヒストンおよび/またはproADM
BR112018016717A2 (pt) 2016-12-16 2018-12-26 H Lundbeck As agentes, usos e métodos
AU2017382404A1 (en) 2016-12-23 2019-07-11 SeLux Diagnostics, Inc. Methods for improved rapid antimicrobial susceptibility testing
WO2018141840A1 (en) 2017-02-02 2018-08-09 B.R.A.H.M.S Gmbh Proadm as marker indicating an adverse event
US20200225248A1 (en) 2017-05-31 2020-07-16 B.R.A.H.M.S Gmbh Mmp-8 as a marker for identifying infectious disease
FR3067349B1 (fr) 2017-06-12 2020-12-04 Cisbio Bioassays Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants
FR3067712B1 (fr) 2017-06-14 2019-08-02 Cisbio Bioassays Nouveaux agents complexants de type trimethoxyphenyl pyridine hydrosolubles et complexes de lanthanide correspondants
FR3069644B1 (fr) 2017-07-28 2024-07-12 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
EP3682241B1 (en) 2017-09-13 2022-03-30 B.R.A.H.M.S GmbH Pct and pro-adm as markers for monitoring antibiotic treatment
US20200271667A1 (en) 2017-09-13 2020-08-27 B.R.A.H.M.S Gmbh Method for guidance of fluid therapy based on proadrenomedullin
EP3502691A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
US11327082B2 (en) 2017-09-13 2022-05-10 B.R.A.H.M.S Gmbh Proadrenomedullin as a marker for abnormal platelet levels
EP3682236A1 (en) 2017-09-13 2020-07-22 B.R.A.H.M.S GmbH Proadrenomedullin as indicator for renal replacement therapy in critically ill patients
WO2019122088A1 (en) 2017-12-20 2019-06-27 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
US20210109118A1 (en) 2017-12-20 2021-04-15 B.R.A.H.M.S Gmbh Antibiotic therapy guidance based on pro-adm
US20200309796A1 (en) 2017-12-21 2020-10-01 H. Lundbeck A/S Assay, method and treatment of alpha-synucleinopathies
EP3578989A1 (en) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
EP3608673A1 (en) 2018-08-08 2020-02-12 B.R.A.H.M.S GmbH Pro-adm for prognosing the risk of a medical condition requiring hospitalization in patients with symptoms of infectious disease
EP3918343A1 (en) 2019-01-28 2021-12-08 B.R.A.H.M.S GmbH Method to predict treatment response in patients with nocturnal enuresis
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
CN113424065A (zh) 2019-02-21 2021-09-21 B.R.A.H.M.S有限公司 对手术后不良事件进行的诊断或预后
EP3715851A1 (en) 2019-03-29 2020-09-30 B.R.A.H.M.S GmbH Prescription of remote patient management based on biomarkers
BR112021019479A2 (pt) 2019-03-29 2021-11-30 Brahms Gmbh Prescrição de gerenciamento de paciente remoto com base em biomarcadores
US11845976B2 (en) 2019-08-27 2023-12-19 SeLux Diagnostics, Inc. Systems and methods for performing antimicrobial susceptibility testing
WO2021204770A1 (en) 2020-04-06 2021-10-14 B.R.A.H.M.S Gmbh Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (sars)
EP4133281A1 (en) 2020-04-09 2023-02-15 B.R.A.H.M.S GmbH Biomarkers for the diagnosis of respiratory tract infections
WO2023104975A1 (en) 2021-12-08 2023-06-15 B.R.A.H.M.S Gmbh Biomarkers for prognosis of early onset preeclampsia
CA3240914A1 (en) 2021-12-13 2023-06-22 Universite Laval Biomarkers for the prediction of preterm birth
WO2024121392A1 (en) 2022-12-08 2024-06-13 B.R.A.H.M.S Gmbh Multiple sflt-1 measurements for prognosis of early onset preeclampsia

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888877A (en) * 1969-06-11 1975-06-10 Schering Corp Macrocyclic compounds and complexes thereof
CA966127A (en) * 1970-05-12 1975-04-15 Marilyn H. Bromels Macrocyclic hetero imine complexing agents
US3847949A (en) * 1970-05-12 1974-11-12 Du Pont Macrocyclic hetero imine complexing agents
US4156683A (en) * 1973-03-26 1979-05-29 Schering Corporation Complexes of macrocyclic compounds
US3966766A (en) * 1973-03-26 1976-06-29 Schering Corporation Monocyclic macrocyclic compounds and complexes thereof
US4058732A (en) * 1975-06-30 1977-11-15 Analytical Radiation Corporation Method and apparatus for improved analytical fluorescent spectroscopy
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
CA1205028A (en) * 1981-07-01 1986-05-27 Jerald C. Hinshaw Fluorescent chelates and labeled specific binding reagents prepared therefrom
DE3202779A1 (de) * 1982-01-28 1983-08-04 Merck Patent Gmbh, 6100 Darmstadt Kaliumreagens und verfahren zur bestimmung von kaliumionen
US4631119A (en) * 1983-11-23 1986-12-23 W. R. Grace & Co. Reversible, electrochemically-switched lariat ethers
US4734376A (en) * 1985-02-04 1988-03-29 The President & Trustees Of The Miami University Process for the spectrophotometric measurement of lithium ion employing a chromogenic aza-12-crown-4- ether
US4659815A (en) * 1985-02-04 1987-04-21 The President And Trustees Of The Miami University Chromogenic aza-12-crown-4 ethers and method of using same for the detection of lithium
GB8528804D0 (en) * 1985-11-22 1985-12-24 Amersham Int Plc Compounds

Also Published As

Publication number Publication date
DE3587380T2 (de) 1994-01-05
JPH0715471B2 (ja) 1995-02-22
JPH06184151A (ja) 1994-07-05
DE3587380D1 (es) 1993-07-08
ES8801938A1 (es) 1988-03-01
US4927923A (en) 1990-05-22
ATE90084T1 (de) 1993-06-15
CA1329593C (en) 1994-05-17
EP0180492A1 (fr) 1986-05-07
ES8801695A1 (es) 1988-02-16
ES557485A0 (es) 1988-02-16
EP0180492B1 (fr) 1993-06-02
JPH06199858A (ja) 1994-07-19
JPH0714935B2 (ja) 1995-02-22
ES8706792A1 (es) 1987-07-01
JPH0655741B2 (ja) 1994-07-27
KR860002553A (ko) 1986-04-26
ES557486A0 (es) 1988-03-01
FR2570703B1 (fr) 1988-07-08
JPS6187680A (ja) 1986-05-06
FR2570703A1 (fr) 1986-03-28
KR930008210B1 (ko) 1993-08-26

Similar Documents

Publication Publication Date Title
ES547294A0 (es) Procedimiento de exaltacion de la fluorescencia de un ion detierra rara
DE3789478D1 (de) Induktiv angeregte Ionenquelle.
ATE28211T1 (de) Stabilisierte klebstoffe.
ES2134051T3 (es) Procedimiento para la preparacion de sildenafil.
DE3673561D1 (de) Fluoreszierende lanthanidchelate.
DE3689349D1 (de) Ionenquelle.
MX3655A (es) Compuestos de bis-fosfito.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
DE3771782D1 (de) Elektronenspektrometer.
DE3782658D1 (de) Ionen-beweglichkeits-spektrometer.
NO873991D0 (no) Ballastreaktans for hoeytrykks natriumdamplamper.
ES8704931A1 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
DE3684029D1 (de) Eine phosphormischung verwendende fluoreszenzlampe.
DE3689428D1 (de) Elektronenstrahlquelle.
DK279586A (da) Indtraengningssko til neddrivning af soejler, isaer foringsroer
DE3689232D1 (de) Ionenquelle.
DE3881579D1 (de) Ionenquelle.
FR2575466B1 (fr) Nouveaux complexes de silicium hexacoordines, leur procede de preparation et leur application
NL189985C (nl) Fluorescentielamp.
FI904852A0 (fi) Antikoagulantpeptider.
DE68920981D1 (de) Trockenmittel für Leuchtstofflampen.
NO873600D0 (no) Stabilisator for foringsroer.
ES2053942T3 (es) Empleo de aductos de oxido de 1,2-butileno en compuestos organicos h-azidas como lubricantes y lubricantes que contienen estos aductos.
DE3575439D1 (de) Phosphor.
DE59007799D1 (de) Getterzusammensetzung für Lichtquellen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070514